Effect of Ramadan fasting in patients with type 2 diabetes mellitus treated with sodium-glucose cotransporter 2 inhibitors: A systematic review and meta-analysis.
Hoda GadNoor Al-NassrIbrahim MohammedAdnan KhanRoss S MacDonaldPaul MusslemanRayaz Ahmed MalikPublished in: Journal of diabetes investigation (2022)
This systematic review and meta-analysis shows that patients with type 2 diabetes treated with SGLT2i's during Ramadan have an improvement in HbA1c, less hypoglycemia and no major adverse effects.